masivet
ab science s.a. - masitinib mesilate - antineoplastična sredstva - psi - liječenje ne-resektabilnih pasa mast-stanica tumora (stupanj 2 ili 3) s potvrđenim mutiranim c-kit tirozin-kinaznim receptorom.
masiviera
ab science - masitinib - neoplazme gušterače - inhibitori протеинкиназы - liječenje operirati lokalno-uobičajena ili metastaze raka gušterače .
masipro
ab science - masitinib mesilate - mastocitoza - antineoplastična sredstva - liječenje мастоцитоза.
masican
masitinib - tumori gastrointestinalnog stroma - inhibitori протеинкиназы - liječenje operirati i/ili метастатической raka стромальной tumora git (gist).
alsitek
ab science - masitinib mesilate - amiotrofna lateralna skleroza - antineoplastična sredstva - liječenje bočnog амиотрофического skleroze.
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib teva 100 mg filmom obložene tablete
teva b.v., swensweg 5, haarlem, nizozemska - dasatinib hidrat - filmom obložena tableta - 100 mg - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba (u obliku hidrata)
dasatinib teva 20 mg filmom obložene tablete
teva b.v., swensweg 5, haarlem, nizozemska - dasatinib hidrat - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba (u obliku hidrata)
dasatinib teva 50 mg filmom obložene tablete
teva b.v., swensweg 5, haarlem, nizozemska - dasatinib hidrat - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg dasatiniba (u obliku hidrata)